NCT00929552

Brief Summary

The aim of the study is to investigate if dietary fish oil has a beneficial effect on blood pressure, insulin sensitivity, blood lipid profile, body composition and metabolic rate in healthy, but slightly overweight, teenage boys. We hypothesized that the n-3 long chain polyunsaturated fatty acids from fish oil might have greater effect during growth and development, as intervention trials studying the effect of fish oil on babies have shown greater effects than in adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2007

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2008

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

June 26, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 29, 2009

Completed
Last Updated

September 26, 2012

Status Verified

September 1, 2012

Enrollment Period

7 months

First QC Date

June 26, 2009

Last Update Submit

September 25, 2012

Conditions

Keywords

Blood pressureInsulin sensitivityBlood lipid profile

Outcome Measures

Primary Outcomes (1)

  • Markers of the metabolic syndrome. Blood pressure, insulin sensitivity, HDL-cholesterol and triacylglycerol.

    Intervention period = 16 weeks

Secondary Outcomes (1)

  • Body composition

    16 weeks

Study Arms (2)

Fish oil

EXPERIMENTAL

Daily dose = 6g fish oil baked into rye bread and wheat rolls. Participants were asked to consume two slices of rye bread and one wheat roll pr day. The fish oil was micro-incapsulated.

Dietary Supplement: Dietary oils (fish, vegetable oil)

Vegetable oil (Mix of canola, palm and soy oil)

ACTIVE COMPARATOR

Daily dose = 6g vegetable oil baked into rye bread and wheat rolls. Participants were asked to consume two slices of rye bread and one wheat roll pr day.

Dietary Supplement: Dietary oils (fish, vegetable oil)

Interventions

6g pr day.

Fish oilVegetable oil (Mix of canola, palm and soy oil)

Eligibility Criteria

Age13 Years - 15 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Weight above the 90th percentile for height and age.

You may not qualify if:

  • Smoking, severe illnesses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Human Nutrition

Frederiksberg, 1958, Denmark

Location

Related Publications (1)

  • Pedersen MH, Molgaard C, Hellgren LI, Lauritzen L. Effects of fish oil supplementation on markers of the metabolic syndrome. J Pediatr. 2010 Sep;157(3):395-400, 400.e1. doi: 10.1016/j.jpeds.2010.04.001. Epub 2010 May 15.

MeSH Terms

Conditions

Metabolic SyndromeInsulin Resistance

Interventions

Dietary Fats, UnsaturatedIn Situ Hybridization, FluorescencePlant Oils

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Dietary FatsFatsLipidsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesIn Situ HybridizationStaining and LabelingHistocytological Preparation TechniquesCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHistological TechniquesInvestigative TechniquesCytogenetic AnalysisGenetic TechniquesNucleic Acid HybridizationOilsPlant PreparationsBiological ProductsComplex Mixtures

Study Officials

  • Lotte Lauritzen, Ph.D.

    University of Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 26, 2009

First Posted

June 29, 2009

Study Start

November 1, 2007

Primary Completion

June 1, 2008

Study Completion

June 1, 2009

Last Updated

September 26, 2012

Record last verified: 2012-09

Locations